JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova Ltd has announced that its management will meet with 29 institutional investors on May 28, 2026, in Mumbai. The meetings are part of the 360 One Capital Trinity India 2026 Conference and will include one-on-one and group interactions. The company will discuss Q4'FY26 earnings results during these meetings, with the earnings presentation scheduled to be filed on May 22, 2026. The investor list includes asset managers, PMS providers, family offices, and alternative investment funds.
This routine regulatory disclosure indicates active investor engagement ahead of Q4 FY26 results. The post-earnings meeting schedule suggests management confidence in financial performance, which could be viewed positively by shareholders.